0001123292-19-000911.txt : 20190626 0001123292-19-000911.hdr.sgml : 20190626 20190626161833 ACCESSION NUMBER: 0001123292-19-000911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190624 FILED AS OF DATE: 20190626 DATE AS OF CHANGE: 20190626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collier William H. CENTRAL INDEX KEY: 0001780495 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 19921819 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA CORPORATION STREET 2: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-06-24 0001447028 Arbutus Biopharma Corp ABUS 0001780495 Collier William H. C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE WARMINSTER PA 18974 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 2.18 2019-06-24 4 A 0 1112000 0 A 2029-06-24 Common Shares 1112000 1112000 D The stock option will vest and become exercisable as to 25% of the common shares on June 24, 2020 and as to an additional 1/48th of the total original number of common shares subject to Mr. Collier's stock option on the corresponding day of each month over the three year period thereafter, subject to Mr. Collier's continued employment with Arbutus Biopharma Corporation through the applicable vesting dates. /s/ David C. Hastings, as attorney-in-fact for William H. Collier 2019-06-26